dobutamine has been researched along with neuropeptide y in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, FL; Bristow, MR; Hanson, G; Hershberger, RE; Kralios, AC; Port, JD; Reid, BB | 1 |
| Benvenuti, C; Bohuon, C; Carville, C; Castaigne, A; Comoy, E; Dubois-Randé, JL; Hittinger, L; Macquin-Mavier, I; Merlet, P | 1 |
| Awad, SJ; Einstein, R; Potter, EK; Richardson, DP | 1 |
| Himura, Y; Kashiki, M; Liang, CS; Stevens, SY | 1 |
4 other study(ies) available for dobutamine and neuropeptide y
| Article | Year |
|---|---|
Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Dopamine; Electrocardiography; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Neuropeptide Y; Receptors, Adrenergic, beta | 1992 |
Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
Topics: Adult; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Coronary Vessels; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Sympathetic Nervous System | 1992 |
The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
Topics: Albuterol; Animals; Blood Pressure; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Guanidines; Heart Rate; Imidazoles; Impromidine; Myocardial Contraction; Neuropeptide Y; Norepinephrine; Parasympathetic Nervous System; Sympathetic Nervous System; Vagus Nerve; Vasopressins | 1991 |
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Cardiotonic Agents; Desipramine; Dobutamine; Dogs; Heart Failure; Immunohistochemistry; Myocardial Contraction; Myocardium; Neuropeptide Y; Norepinephrine; Organ Size; Presynaptic Terminals; Receptors, Adrenergic, beta; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Dysfunction, Right | 2002 |